Weight Loss Drug Belviq May Increase Cancer Risk, FDA Reports
FDA warns the obesity-fighting drug, Belviq, might be associated with an increased risk of cancer.
Read Original Article: Weight Loss Drug Belviq May Increase Cancer Risk, FDA Reports »

FDA warns the obesity-fighting drug, Belviq, might be associated with an increased risk of cancer.
Read Original Article: Weight Loss Drug Belviq May Increase Cancer Risk, FDA Reports »